Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart pillbox reveals real lithium habits

NCT ID NCT07167563

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study uses a special pillbox that records when people with bipolar disorder take their lithium. Over four weeks, 50 participants will use the pillbox and get weekly phone calls to compare what they remember with what the box recorded. The goal is to see how well people stick to their lithium schedule in real life, not in a controlled lab setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lithium
What this could lead to
If successful, this could help doctors understand real-world medication habits and improve support for people with bipolar disorder.
What could go wrong
This is a small, observational study that does not test a new treatment. It only measures behavior, so it cannot directly improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Any patient aged ≥18 years diagnosed with bipolar disorder followed at the bipolar disorder outpatient unit at AUHP, treated with lithium and without any coercive measure or forensic psychiatry sanction at the time of inclusion will be eligible for inclusion in the study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥18 years 2. Diagnosed with bipolar disorder (ICD-10: F30-31) 3. Followed at the bipolar disorder outpatient clinic at AUHP 4. Treated with lithium (ATC-code: N05AN01) 5. Able to give informed oral and written consent. Exclusion Criteria: 1. Any coercive measure in the study period including patients in forensic psychiatry. 2. In a clinical condition where the treating clinician evaluates that the patient is not able to attend the research study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bipolar disorder (BD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinic for Bipolar Disorder, Aarhus University Hospital Psychiatry

    RECRUITING

    Aarhus, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.